John Paulson Insider Trading $BVF Bausch Health Companies Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Paulson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Paulson. John Paulson is Director in AMERICAN INTERNATIONAL GROUP INC ($AIG) and in Bausch Health Companies Inc. ($BVF) and Director in Valeant Pharmaceuticals International, Inc. ($BVF) and Director in BrightSphere Investment Group plc ($OMAM) and in BrightSphere Investment Group Inc. ($BSIG).
John Paulson in Bausch Health Companies Inc.
Trading Symbol: BVFIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John Paulson: Director
Holdings: 82,037 shares
Latest Transaction: May 03 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John Paulson in Bausch Health Companies Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIG, BVF, BSIG, OMAM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2021 | BVF | Bausch Health Comp ... | Paulson John | Director | Grant | A | 0.00 | 7,645 | 0 | 82,037 | 74.4 K to 82 K (+10.28 %) |
Apr 02 2021 | BVF | Bausch Health Comp ... | Paulson John | Director | Grant | A | 31.74 | 952 | 30,216 | 74,392 | 73.4 K to 74.4 K (+1.30 %) |
Jan 04 2021 | BVF | Bausch Health Comp ... | Paulson John | Director | Grant | A | 20.80 | 1,442 | 29,994 | 73,440 | 72 K to 73.4 K (+2.00 %) |
Oct 02 2020 | BVF | Bausch Health Comp ... | Paulson John | Director | Grant | A | 15.54 | 1,930 | 29,992 | 71,998 | 70.1 K to 72 K (+2.75 %) |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 15.92 | 585,100 | 9,314,792 | 25,839,035 | 25.3 M to 25.8 M (+2.32 %) | |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 15.87 | 624,900 | 9,917,163 | 25,253,935 | 24.6 M to 25.3 M (+2.54 %) | |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 15.65 | 70,000 | 1,095,500 | 24,629,035 | 24.6 M to 24.6 M (+0.29 %) | |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 15.85 | 348,920 | 5,530,382 | 24,559,035 | 24.2 M to 24.6 M (+1.44 %) | |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 16.70 | 645,844 | 10,785,595 | 24,210,115 | 23.6 M to 24.2 M (+2.74 %) | |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 16.58 | 80,300 | 1,331,374 | 23,564,271 | 23.5 M to 23.6 M (+0.34 %) | |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 16.32 | 603,900 | 9,855,648 | 23,483,971 | 22.9 M to 23.5 M (+2.64 %) | |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 17.24 | 799,900 | 13,790,276 | 22,880,071 | 22.1 M to 22.9 M (+3.62 %) | |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 17.47 | 678,400 | 11,851,648 | 22,080,171 | 21.4 M to 22.1 M (+3.17 %) | |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 17.33 | 374,836 | 6,495,908 | 21,401,771 | 21 M to 21.4 M (+1.78 %) | |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 17.50 | 162,900 | 2,850,750 | 21,026,935 | 20.9 M to 21 M (+0.78 %) | |
May 14 2020 | BVF | Bausch Health Comp ... | Paulson John | Buy | P | 17.30 | 25,000 | 432,500 | 20,864,035 | 20.8 M to 20.9 M (+0.12 %) | |
May 01 2020 | BVF | Bausch Health Comp ... | Paulson John | Director | Grant | A | 0.00 | 11,037 | 0 | 68,523 | 57.5 K to 68.5 K (+19.20 %) |
Apr 02 2020 | BVF | Bausch Health Comp ... | Paulson John | Director | Grant | A | 15.50 | 1,774 | 27,497 | 57,486 | 55.7 K to 57.5 K (+3.18 %) |
Jan 02 2020 | BVF | Bausch Health Comp ... | Paulson John | Director | Grant | A | 29.92 | 919 | 27,496 | 55,712 | 54.8 K to 55.7 K (+1.68 %) |
Oct 02 2019 | BVF | Bausch Health Comp ... | Paulson John | Director | Grant | A | 21.85 | 1,258 | 27,487 | 54,793 | 53.5 K to 54.8 K (+2.35 %) |
May 03 2019 | BVF | Bausch Health Comp ... | Paulson John | Director | Grant | A | 23.51 | 10,633 | 249,982 | 52,445 | 41.8 K to 52.4 K (+25.43 %) |
Apr 03 2019 | BVF | Bausch Health Comp ... | Paulson John | Director | Grant | A | 24.70 | 1,113 | 27,491 | 41,812 | 40.7 K to 41.8 K (+2.73 %) |
Oct 02 2018 | BVF | Bausch Health Comp ... | Paulson John | Director | Grant | A | 25.67 | 1,071 | 27,493 | 39,211 | 38.1 K to 39.2 K (+2.81 %) |
Jul 03 2018 | BVF | Valeant Pharmaceut ... | Paulson John | Director | Grant | A | 23.24 | 1,183 | 27,493 | 38,140 | 37 K to 38.1 K (+3.20 %) |
May 04 2018 | BVF | Valeant Pharmaceut ... | Paulson John | Director | Grant | A | 0.00 | 14,285 | 0 | 37,361 | 23.1 K to 37.4 K (+61.90 %) |
Apr 03 2018 | BVF | Valeant Pharmaceut ... | Paulson John | Director | Grant | A | 15.92 | 1,727 | 27,494 | 23,076 | 21.3 K to 23.1 K (+8.09 %) |
Mar 08 2018 | BVF | Valeant Pharmaceut ... | Paulson John | Director | Buy | P | 15.40 | 7,066,629 | 108,826,087 | 20,839,035 | 13.8 M to 20.8 M (+51.31 %) |
Mar 08 2018 | BVF | Valeant Pharmaceut ... | Paulson John | Director | Sell | S | 15.40 | 7,066,629 | 108,826,087 | 13,772,406 | 20.8 M to 13.8 M (-33.91 %) |
Nov 20 2017 | BVF | Valeant Pharmaceut ... | Paulson John | Director | Sell | S | 14.39 | 344,216 | 4,952,821 | 20,839,035 | 21.2 M to 20.8 M (-1.62 %) |
Nov 20 2017 | BVF | Valeant Pharmaceut ... | Paulson John | Director | Buy | P | 14.40 | 344,216 | 4,955,506 | 21,183,251 | 20.8 M to 21.2 M (+1.65 %) |
Oct 04 2017 | BVF | Valeant Pharmaceut ... | Paulson John | Director | Grant | A | 14.33 | 1,860 | 26,654 | 20,026 | 18.2 K to 20 K (+10.24 %) |
Aug 10 2017 | BVF | Valeant Pharmaceut ... | Paulson John | Director | Grant | A | 14.66 | 974,365 | 14,283,704 | 20,839,035 | 21.8 M to 20.8 M (-4.47 %) |
Jul 05 2017 | BVF | Valeant Pharmaceut ... | Paulson John | Director | Grant | A | 0.00 | 269 | 0 | 18,166 | 17.9 K to 18.2 K (+1.50 %) |
Page: 1